Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rutkowski

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 21, 2007
Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic strokeGiora Z Feuerstein, Margaret M Zaleska, Michael Krams, et al.
Journal of Pineal Research|May 30, 2012
Effects on bone by the light/dark cycle and chronic treatment with melatonin and/or hormone replacement therapy in intact female micePaula A Witt-Enderby, John P Slater, Nakpangi A Johnson, et al.
The Review of Scientific Instruments|January 30, 2021
A new instrument for kinetics and branching ratio studies of gas phase collisional processes at very low temperaturesO Durif, M Capron, J P Messinger, et al.
The Journal of Oral Implantology|August 24, 2012
Impact factors in scientific journals: keeping a balance for the JOI readersJames L Rutkowski, Sheldon Winkler, Robert J Buhite, et al.
Journal of Neurogenetics|September 19, 2000
Advances in neurofibromatosis 2 (NF2): a workshop reportD J Lim, A E Rubenstein, D G Evans, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2022
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue SarcomaSylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, et al.
The Lancet. Oncology|July 13, 2019
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trialSylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 21, 2007
Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic strokeGiora Z Feuerstein, Margaret M Zaleska, Michael Krams, et al.
Journal of Pineal Research|May 30, 2012
Effects on bone by the light/dark cycle and chronic treatment with melatonin and/or hormone replacement therapy in intact female micePaula A Witt-Enderby, John P Slater, Nakpangi A Johnson, et al.
The Review of Scientific Instruments|January 30, 2021
A new instrument for kinetics and branching ratio studies of gas phase collisional processes at very low temperaturesO Durif, M Capron, J P Messinger, et al.
The Journal of Oral Implantology|August 24, 2012
Impact factors in scientific journals: keeping a balance for the JOI readersJames L Rutkowski, Sheldon Winkler, Robert J Buhite, et al.
Journal of Neurogenetics|September 19, 2000
Advances in neurofibromatosis 2 (NF2): a workshop reportD J Lim, A E Rubenstein, D G Evans, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2022
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue SarcomaSylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, et al.
The Lancet. Oncology|July 13, 2019
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trialSylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, et al.
Pageof 14